Cargando…
Barriers to effective treatment of vaginal atrophy with local estrogen therapy
Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunate...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603331/ https://www.ncbi.nlm.nih.gov/pubmed/23525842 http://dx.doi.org/10.2147/IJGM.S43192 |
_version_ | 1782263671746985984 |
---|---|
author | Reiter, Suzanne |
author_facet | Reiter, Suzanne |
author_sort | Reiter, Suzanne |
collection | PubMed |
description | Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunately, few women with symptoms of vaginal atrophy report seeking treatment from a health care provider. The goal of this article is to examine reasons why patients and health care providers do not engage in discourse regarding this important topic. It is important to initiate conversations with postmenopausal women and counsel them on both why the changes occur and potential treatment options. |
format | Online Article Text |
id | pubmed-3603331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36033312013-03-22 Barriers to effective treatment of vaginal atrophy with local estrogen therapy Reiter, Suzanne Int J Gen Med Review Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunately, few women with symptoms of vaginal atrophy report seeking treatment from a health care provider. The goal of this article is to examine reasons why patients and health care providers do not engage in discourse regarding this important topic. It is important to initiate conversations with postmenopausal women and counsel them on both why the changes occur and potential treatment options. Dove Medical Press 2013-03-15 /pmc/articles/PMC3603331/ /pubmed/23525842 http://dx.doi.org/10.2147/IJGM.S43192 Text en © 2013 Reiter, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Reiter, Suzanne Barriers to effective treatment of vaginal atrophy with local estrogen therapy |
title | Barriers to effective treatment of vaginal atrophy with local estrogen therapy |
title_full | Barriers to effective treatment of vaginal atrophy with local estrogen therapy |
title_fullStr | Barriers to effective treatment of vaginal atrophy with local estrogen therapy |
title_full_unstemmed | Barriers to effective treatment of vaginal atrophy with local estrogen therapy |
title_short | Barriers to effective treatment of vaginal atrophy with local estrogen therapy |
title_sort | barriers to effective treatment of vaginal atrophy with local estrogen therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603331/ https://www.ncbi.nlm.nih.gov/pubmed/23525842 http://dx.doi.org/10.2147/IJGM.S43192 |
work_keys_str_mv | AT reitersuzanne barrierstoeffectivetreatmentofvaginalatrophywithlocalestrogentherapy |